Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease

Atherosclerosis

Volumn 172, Issue 2, 2004, Pages 345-351

  Anderson, Ross ^a   Dart, Anthony M ^a   Starr, Jennifer ^a   Shaw, James ^a   Chin Dusting, Jaye P F ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

C reactive protein; Coronary artery disease; Endothelium

Indexed keywords

ACETYLCHOLINE; C REACTIVE PROTEIN; PADGEM PROTEIN; PROTEIN S; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; FOREARM BLOOD FLOW; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; VEIN DILATATION; VEIN OCCLUSION PLETHYSMOGRAPHY;

EID: 0842324550     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2003.10.009     Document Type: Article

References (25)

1. Creager M.A., Cooke J.P., Mendelsohn M.E., Gallagher S.J., Coleman S.M., Loscalzo J.et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J. Clin. Invest. 86:1990;228-234.
2. Chin J.P.F., Dart A.M. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils. Clin. Exp. Pharmacol. Physiol. 21:1994;749-755.
3. Panza J.A., Quyyumi A.A., Brush J.E. Jr., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323:1990;22-27.
4. Heitzer T., Schlinzig T., Krohn K., Meinertz T., Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 104(22):2001;2673-2678.
5. Katz S.D., Schwarz M., Yuen J., LeJemtel T.H. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Circulation. 88:1993;55-61.
6. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D.et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
7. Clarkson P., Celermajer D.S., Powe A.J., Donald A.E., Henry R.M., Deanfield J.E. Endothelium-dependent dilatation is impaired in young healthy subjects with a family history of premature coronary artery disease. Circulation. 96:1997;3378-3383.
8. Fichtlscherer S., Rosenberger G., Walter D.H., Breuer S., Dimmeler S., Zeiher A.M. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 102(9):2000;1000-1006.
9. Khan B.V., Harrison D.G., Olbrych M.T., Alexander R.W., Medford R.M. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 93(17):1996;9114-9119.
10. Yap S.H., Moshage H.J., Hazenberg B.P., Roelofs H.M., Bijzet J., Limburg P.C.et al. Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes. Biochim. Biophys. Acta. 1091(3):1991;405-408.
11. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A.et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 99(2):1999;237-242.
12. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 349(9050):1997;462-466.
13. Dart A.M., Cooper B., Kay S.B., Salem H. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease. Atherosclerosis. 140(1):1998;55-64.
14. Lieberman E.H., Gerhard M.D., Uehata A., Selwyn A.P., Ganz P., Yeung A.C.et al. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am. J. Cardiol. 78(11):1996;1210-1214.
15. Duffy S.J., Biegelsen E.S., Holbrook M., Russell J.D., Gokce N., Keaney J.F. Jr.et al. Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 103(23):2001;2799-2804.
16. Miller F.J. Jr., Gutterman D.D., Rios C.D., Heistad D.D., Davidson B.L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82(12):1998;1298-1305.
17. Oelze M., Mollnau H., Hoffmann N., Warnholtz A., Bodenschatz M., Smolenski A.et al. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. Circ. Res. 87(11):2000;999-1005.
18. Zeiher A.M., Schachinger V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 92(5):1995;1094-1100.
19. Heitzer T., Yla-Herttuala S., Luoma J., Kurz S., Munzel T., Just H.et al. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL. Circulation. 93:1996;1346-1353.
20. Heitzer T., Just H., Munzel T. Antioxidant Vitamin C improves endothelial dysfunction in chronic smokers. Circulation. 94(1):1996;6-9.
21. McVeigh G.E., Lemay L., Morgan D., Cohn J.N. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am. J. Cardiol. 78(6):1996;668-672.
22. Kanthou C., Benzakour O. Cellular effects and signalling pathways activated by the anti-coagulant factor, protein S, in vascular cells protein S cellular effects. Adv. Exp. Med. Biol. 476:2000;155-166.
23. van Mourik J.A., Romani de Wit T., Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem. Cell Biol. 117(2):2002;113-122.
24. Hollestelle M.J., Thinnes T., Crain K., Stiko A., Kruijt J.K., van Berkel T.J. Tissue distribution of factor VIII gene expression in vivo - a closer look. Thromb. Haemost. 86(3):2001;855-861.
25. Andersen G.N., Caidahl K., Kazzam E., Petersson A.S., Waldenstrom A., Mincheva-Nilsson L.et al. Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin. Arthritis Rheum. 43(5):2000;1085-1093.